{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:40:24Z","timestamp":1772757624266,"version":"3.50.1"},"reference-count":48,"publisher":"American Chemical Society (ACS)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bioconjugate Chem."],"published-print":{"date-parts":[[2001,7,1]]},"DOI":"10.1021\/bc010012p","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T04:49:41Z","timestamp":1027658981000},"page":"624-629","source":"Crossref","is-referenced-by-count":60,"title":["<sup>99m<\/sup>Tc-Labeling of a Hydrazinonicotinamide-Conjugated Vitronectin Receptor Antagonist Useful for Imaging Tumors"],"prefix":"10.1021","volume":"12","author":[{"given":"Shuang","family":"Liu","sequence":"first","affiliation":[{"name":"Medical Imaging Division, DuPont Pharmaceuticals Company,331 Treble Cove Road, North Billerica, Massachusetts 01862"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Scott","family":"Edwards","sequence":"additional","affiliation":[{"name":"Medical Imaging Division, DuPont Pharmaceuticals Company,331 Treble Cove Road, North Billerica, Massachusetts 01862"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisa C.","family":"Ziegler","sequence":"additional","affiliation":[{"name":"Medical Imaging Division, DuPont Pharmaceuticals Company,331 Treble Cove Road, North Billerica, Massachusetts 01862"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony R.","family":"Harris","sequence":"additional","affiliation":[{"name":"Medical Imaging Division, DuPont Pharmaceuticals Company,331 Treble Cove Road, North Billerica, Massachusetts 01862"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart J.","family":"Hemingway","sequence":"additional","affiliation":[{"name":"Medical Imaging Division, DuPont Pharmaceuticals Company,331 Treble Cove Road, North Billerica, Massachusetts 01862"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Barrett","sequence":"additional","affiliation":[{"name":"Medical Imaging Division, DuPont Pharmaceuticals Company,331 Treble Cove Road, North Billerica, Massachusetts 01862"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"316","published-online":{"date-parts":[[2001,6,7]]},"reference":[{"key":"bc010012pb00001\/bc010012pb00001_1","volume":"40","author":"Lister-James J.","year":"1996","journal-title":"Q. J. Nucl. Med."},{"key":"bc010012pb00002\/bc010012pb00002_1","volume-title":"Recent developments of Tc-99m-labeled peptide-based radiopharmaceuticals:\u2009 a review. Nucl. Med. Commun. 20, 1093\u22121112","author":"Okarvi S. M.","year":"1999"},{"key":"bc010012pb00003\/bc010012pb00003_1","first-page":"8","volume":"43","author":"Weiner R. E.","year":"1999","journal-title":"Q. J. Nucl. Med."},{"key":"bc010012pb00004\/bc010012pb00004_1","volume":"99","author":"Liu S.","year":"1999","journal-title":"Chem. Rev."},{"key":"bc010012pb00005\/bc010012pb00005_1","doi-asserted-by":"crossref","DOI":"10.1021\/cr9804386","volume":"99","author":"Volkert W. A.","year":"1999","journal-title":"Chem. Rev."},{"key":"bc010012pb00006\/bc010012pb00006_1","doi-asserted-by":"crossref","DOI":"10.1021\/cr980435t","volume":"99","author":"Jurisson S.","year":"1999","journal-title":"Chem. Rev."},{"key":"bc010012pb00007\/bc010012pb00007_1","doi-asserted-by":"crossref","DOI":"10.1021\/cr980451q","volume":"99","author":"Anderson C. J.","year":"1999","journal-title":"Chem. Rev."},{"key":"bc010012pb00008\/bc010012pb00008_1","volume-title":"Receptor targeting for tumor localization and therapy with radiopeptides. Curr. Pharm. Des. 6, 971\u2212994","author":"Heppeler H.","year":"2000"},{"key":"bc010012pb00009\/bc010012pb00009_1","volume-title":"Radiopharmaceuticals for the visualization of infectious and inflammatory lessions. Curr. Pharm. Des. 6, 1159\u22121177","author":"Ercan M. T.","year":"2000"},{"key":"bc010012pb00010\/bc010012pb00010_1","volume-title":"Radio-labeled receptor-binding peptides:\u2009 a new class of radiopharmaceuticals. Semin. Nucl. Med. 30, 195\u2212208","author":"Boerman O. C.","year":"2000"},{"key":"bc010012pb00011\/bc010012pb00011_1","first-page":"70","volume":"7","author":"Liu S.","year":"1996","journal-title":"Bioconjugate Chem."},{"key":"bc010012pb00012\/bc010012pb00012_1","volume-title":"Labeling cyclic GPIIb\/IIIa receptor antagonists with 99mTc by the preformed chelate approach:\u2009 Effects of chelators on properties of 99mTc-chelator-peptide conjugates. Bioconjugate Chem. 7, 196\u2212202","author":"Liu S.","year":"1996"},{"key":"bc010012pb00013\/bc010012pb00013_1","doi-asserted-by":"crossref","unstructured":"Barrett, J. A., Damphousse, D. J., Heminway, S. J., Liu, S., Edwards, D. S., and Carroll, T. R. (1996) Biological evaluation of99mTc-labeled cyclic GPIIb\/IIIa receptor antagonists in canine arteriovenous shunt and deep vein thrombosis models:\u2009 effects of chelators on biological properties of99mTc-chelator-peptide conjugates.Bioconjugate Chem.7, 203\u2212208.","DOI":"10.1021\/bc9500960"},{"key":"bc010012pb00014\/bc010012pb00014_1","doi-asserted-by":"crossref","unstructured":"Edwards, D. S., Liu, S., Barrett, J. A., Harris, A. R., Looby, R. J., Ziegler, M. C., Heminway, S. J., and Carroll, T. R. (1997) A new and versatile ternary ligand system for technetium radiopharmaceuticals:\u2009 water soluble phosphines and tricine as coligands in labeling a hydrazino nicotinamide-modified cyclic glycoprotein IIb\/IIIa receptor antagonist with99mTc.Bioconjugate Chem.8, 146\u2212154.","DOI":"10.1021\/bc970002h"},{"key":"bc010012pb00015\/bc010012pb00015_1","doi-asserted-by":"crossref","unstructured":"Barrett, J. A., Crocker, A. C., Damphousse, D. J., Heminway, S. J., Liu, S., Edwards, D. S., Lazewatsky, J. L., Kagan, M., Mazaika, T. J., and Carroll, T. R. (1997) Biological evaluation of thrombus imaging agents utilizing water soluble phosphines and tricine as coligands to label a hydrazinonicotinamide-modified cyclic glycoprotein IIb\/IIIa receptor antagonist with99mTc.Bioconjuate Chem.8, 155\u2212160.","DOI":"10.1021\/bc970001p"},{"key":"bc010012pb00016\/bc010012pb00016_1","first-page":"595","volume":"9","author":"Liu S.","year":"1998","journal-title":"Bioconjuate Chem."},{"key":"bc010012pb00017\/bc010012pb00017_1","volume-title":"99mTc-labeling hydrazones of a hydrazinonicotinamide conjugated cyclic peptide. Bioconjuate Chem. 10, 803\u2212807","author":"Edwards D. S.","year":"1999"},{"key":"bc010012pb00018\/bc010012pb00018_1","volume-title":"Technetium complexes of a hydrazinonicotinamide-conjugated cyclic peptide and 2-hydrazinopyridine:\u2009 Synthesis and characterization. Inorg. Chem. 38, 1326\u22121335","author":"Liu S.","year":"1999"},{"key":"bc010012pb00019\/bc010012pb00019_1","volume-title":"RP463:\u2009 A stabilized technetium-99m complex of a hydrazino nicotinamide conjugated chemotactic peptide for infection imaging. Bioconjuate Chem. 10, 884\u2212891","author":"Edwards D. S.","year":"1999"},{"key":"bc010012pb00020\/bc010012pb00020_1","author":"Rajopadhye M.","year":"1999","journal-title":"J. Labeled Compds Radiopharm. 42 (suppl.), S234\u2212S236."},{"key":"bc010012pb00021\/bc010012pb00021_1","volume":"42","author":"Harris T. D.","year":"1999","journal-title":"J. Labeled Compds Radiopharm."},{"key":"bc010012pb00022\/bc010012pb00022_1","volume":"42","author":"Cheesman E. H.","year":"1999","journal-title":"J. Labeled Compds Radiopharm."},{"key":"bc010012pb00023\/bc010012pb00023_1","volume":"90","author":"Liu S.","year":"2001","journal-title":"J. Pharm. Sci."},{"key":"bc010012pb00024\/bc010012pb00024_1","first-page":"259P","volume":"41","author":"Barrett J. A.","year":"2000","journal-title":"J. Nucl. Med."},{"key":"bc010012pb00025\/bc010012pb00025_1","first-page":"34P","volume":"41","author":"Rajopadhye M.","year":"2000","journal-title":"J. Nucl. Med."},{"key":"bc010012pb00026\/bc010012pb00026_1","first-page":"248","volume":"4","author":"Kuntz E.","year":"1981","journal-title":"U.S. Patent"},{"key":"bc010012pb00027\/bc010012pb00027_1","volume":"118","author":"Haubner R.","year":"1996","journal-title":"J. Am. Chem. Soc."},{"key":"bc010012pb00029\/bc010012pb00029_1","volume":"35","author":"Smith J. W.","year":"1988","journal-title":"J. Biol. Chem."},{"key":"bc010012pb00030\/bc010012pb00030_1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nm0195-27","volume":"1","author":"Folkman J.","year":"1995","journal-title":"Nature Med."},{"key":"bc010012pb00031\/bc010012pb00031_1","doi-asserted-by":"crossref","DOI":"10.1146\/annurev.bi.55.070186.005133","volume":"55","author":"Liotta L. A.","year":"1986","journal-title":"Annu. Rev. Biochem."},{"key":"bc010012pb00032\/bc010012pb00032_1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1358\/dof.1998.023.01.858340","volume":"23","author":"Mousa S. A.","year":"1998","journal-title":"Drugs Future"},{"key":"bc010012pb00033\/bc010012pb00033_1","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.1996.14.2.405","volume":"14","author":"Meitar D.","year":"1996","journal-title":"J. Clinical Oncol."},{"key":"bc010012pb00034\/bc010012pb00034_1","volume-title":"Angiogenesis and colonization in tumor metastatic process:\u2009 basis and applied advances. FASEB 8, 401\u2212407","author":"Weinstat-Saslow D.","year":"1994"},{"key":"bc010012pb00035\/bc010012pb00035_1","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/0140-6736(92)93150-L","volume":"340","author":"Horak E. R.","year":"1992","journal-title":"Lancet"},{"key":"bc010012pb00036\/bc010012pb00036_1","first-page":"410","volume":"1032","author":"Blood C. H.","year":"1990","journal-title":"Biochim. Biophys. Acta"},{"key":"bc010012pb00037\/bc010012pb00037_1","volume-title":"Vascular integrin \u03b1v\u03b23:\u2009 a new prognostic indicator in breast cancer. Clinical Can. Res. 4, 2625\u22122634","author":"Gasparini G.","year":"1998"},{"key":"bc010012pb00038\/bc010012pb00038_1","volume-title":"Clinical applications of angiogenic growth factors and their inhibitors. Nature Med. 5, 1359\u22121364","author":"Ferrara N.","year":"1999"},{"key":"bc010012pb00039\/bc010012pb00039_1","volume-title":"S60\u2212S63.","author":"van Hinsbergh V. W. M.","year":"1999"},{"key":"bc010012pb00040\/bc010012pb00040_1","volume-title":"Tumor angiogenesis-new drug on the block. Nature Biol. 17, 963\u2212968","author":"Brower V.","year":"1999"},{"key":"bc010012pb00041\/bc010012pb00041_1","volume-title":"Integrin \u03b1v\u03b23 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157\u22121164","author":"Brooks P. C.","year":"1994"},{"key":"bc010012pb00042\/bc010012pb00042_1","volume-title":"Engl. 36, 588\u2212590.","author":"Giannis A.","year":"1997"},{"key":"bc010012pb00043\/bc010012pb00043_1","volume-title":"Engl. 36, 1374\u22121389.","author":"Haubner R.","year":"1997"},{"key":"bc010012pb00044\/bc010012pb00044_1","volume-title":"Identification and invivo efficacy of small molecule antagonists of integrin \u03b1v\u03b23 (the vitronectin receptor). DDT 5, 397\u2212408","author":"Miller W. H.","year":"2000"},{"key":"bc010012pb00045\/bc010012pb00045_1","volume-title":"An antagonist of integrin \u03b1v\u03b23 prevents maturation of blood vessels during embryonic neovascularization J. Cell Sci. 108, 2655\u22122661","author":"Drake C. J.","year":"1995"},{"key":"bc010012pb00046\/bc010012pb00046_1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0014-5793(91)81101-D","volume":"291","author":"Aumailley M.","year":"1991","journal-title":"FEBS Lett."},{"key":"bc010012pb00047\/bc010012pb00047_1","volume":"40","author":"Huabner R.","year":"1997","journal-title":"J. Labeled Compds Radiopharm."},{"key":"bc010012pb00048\/bc010012pb00048_1","volume":"40","author":"Haubner R.","year":"1999","journal-title":"J. Nucl. Med."},{"key":"bc010012pb00049\/bc010012pb00049_1","volume-title":"Radio-LC-MS for the characterization of 99mTc-labeled bioconjugates. Bioconjugate Chem. 11, 113\u2212117","author":"Liu S.","year":"2000"}],"container-title":["Bioconjugate Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/bc010012p","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T08:15:42Z","timestamp":1679559342000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/bc010012p"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6,7]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,7,1]]}},"alternative-id":["10.1021\/bc010012p"],"URL":"https:\/\/doi.org\/10.1021\/bc010012p","relation":{},"ISSN":["1043-1802","1520-4812"],"issn-type":[{"value":"1043-1802","type":"print"},{"value":"1520-4812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6,7]]}}}